News

• IGTP joins new ISIDORE project for cross-research activity: PATH2XNAT

  PATH2XNAT is a collaborative effort that merges the capabilities of 3 European research infrastructures: Euro-BioImaging, ELIXIR, and EATRIS through a consortium comprised by the following partners: Germans Trias i Pujol Research Institute (IGTP), EMC and Charité Universitätsmedizin Berlin.

• IGTP and EATRIS strengthen ties with a symposium focused on driving translational research with patient involvement

  IGTP has held an event to share resources, perspectives, and advancements as a centre linked to EATRIS, with a special focus on patient involvement in biomedical research.

• The Core Facilities of the Can Ruti Campus: cutting-edge technology driving excellence in research

  At the Campus Can Ruti Core Facilities Infoday, the Josep Carreras Leukaemia Research Institute and the Germans Trias i Pujol Research Institute showcased their scientific services and the support they can offer to research conducted both on the campus and externally. The event also featured the presentation of the new IGTP-IJC Joint Flow Cytometry Unit, which has one of the most advanced infrastructures in the EU, as well as the new IJC's Translational-PATH2CURE hub, which aims to accelerate the translation of scientific discoveries into treatments for patients.